Product Image

Boswellia Extract 600 mg

Herbal Secrets
4.7
★ ★ ★ ★ ★
(172 ratings)
Boswellia 600 mg
Product Image
Score81
Boswellia Extract 600 mg provides focused Boswellia support in a practical format. Boswellic-acid percentage, AKBA yield, and absorption support are not disclosed, so the active potency cannot be judged from the large headline amount.
How scoring works
Quantity:120 Capsule(s) • (120 servings)
Goals:
Anti-Inflammatory Support
Joint Health

Score 81

Boswellia Extract 600 mg provides focused Boswellia support in a practical format. Boswellic-acid percentage, AKBA yield, and absorption support are not disclosed, so the active potency cannot be judged from the large headline amount.
How scoring works
$12.99($0.10 per serving)
iHerb
$ 14.29
Pure Formulas
$ 12.99
Vitacost
$ 14.29
Report prices

Analysis

Each capsule supplies 600 mg of Boswellia serrata gum-resin extract. The substantial extract amount and single-ingredient design provide focused, economical Boswellia use.

Boswellia is commonly used to support joint comfort and a normal inflammatory response through its boswellic acids. A focused formula makes that purpose easy to understand, although active-marker disclosure determines how confidently the extract can be compared.

Boswellic-acid percentage, AKBA yield, and absorption support are not disclosed, so the active potency cannot be judged from the large headline amount. The 120-serving capsule supply should therefore be judged by active-form clarity and suitability, not just the listed botanical weight.

Who is it for
  • Adults seeking a high-amount standalone Boswellia extract
  • People who prefer supplements in capsule form
  • Users who prefer a clearly focused botanical formula
Best for
  • Focused joint-comfort and inflammatory-pathway support
  • Normal inflammatory-response support
  • A routine with 120 servings per container

Pros

  • The substantial extract amount and single-ingredient design provide focused, economical Boswellia use
  • 120 servings per container
  • Single-ingredient design keeps the purpose clear

Cons

  • Boswellic-acid percentage, AKBA yield, and absorption support are not disclosed, so the active potency cannot be judged from the large headline amount.
  • Single-botanical scope does not cover cartilage structure or joint lubrication.
  • Capsule-only delivery may not suit people who avoid pills.

Warnings

  • Boswellia may add to bleeding tendency with anticoagulant or antiplatelet medicines, so this specific combination warrants medication review.
  • Count other Boswellia products when assessing total daily intake because the active boswellic-acid and AKBA yields may not be fully disclosed.
  • A new rash, digestive upset, or other persistent intolerance after starting Boswellia warrants stopping use and reassessing the product.

Nutrient quality

85 Highest impact

The substantial extract amount and focused composition fit the intended use well. Unspecified boswellic-acid strength and lack of absorption support limit confidence in effective potency.

Ingredient transparency

79 High impact

The active amount is clear and no proprietary blend is used. Missing potency standards, directions, and non-active ingredients leave important label details incomplete.

Customer satisfaction

67 High impact

The supplied average rating is strong and the rating volume is moderate. No specific experience details were provided to judge repeated complaints or purpose alignment.

Value for money

91 Highest impact

A large extract amount at an efficient serving cost provides good practical value. Better standardization would make the comparison with higher-quality Boswellia products more reliable.

Report analysis

Goals

Anti-Inflammatory Support
Impact
Highest effect
A Goal FitB- Strength of SupportC CoverageA+ Formula Quality
Boswellia · 600 mg

Boswellia directly targets the 5-LOX pathway and is closely aligned with inflammation-focused support. The large extract amount is useful, but no boswellic-acid percentage or AKBA yield is stated.

The focused formula may provide meaningful depth despite uncertain active-compound potency. Boswellia may increase bleeding tendency when combined with anticoagulant or antiplatelet medicines.

Study evidence
Boswellia Supportive 19 studies
Joint Health
Impact
High effect
A Goal FitB- Strength of SupportC- CoverageA+ Formula Quality
Boswellia · 600 mg

Boswellia directly targets the 5-LOX inflammatory pathway relevant to joint pain and stiffness. Standardized boswellia extracts have strong human evidence for improving osteoarthritis comfort and function.

The 600 mg extract amount is substantial, but the actual boswellic acid and AKBA yields are unknown. The plant and extract amount are clear, while missing standardization and absorption support limit form quality.

Study evidence
Boswellia Supportive 24 studies

Ingredients

IngredientAmount per serving
Boswellia serrata Gum Resin Extract (Boswellic Acids)
600 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
F Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyB- Value

A large Boswellia extract amount is provided, but the label does not state a boswellic acid percentage. Boswellic acids are named without AKBA detail, and the capsule has no absorption enhancer. The low serving cost provides good practical value despite incomplete potency information.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis.
    Dalmonte T; Andreani G; Rudelli C; Isani G · Phytotherapy research : PTR · 2024
    Meta-analysis1,185 participants13 studies pooledJoint Health forBoswellia
  2. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.
    Holtmeier W; Zeuzem S; Preiss J; Kruis W; Böhm S; Maaser C; Raedler A; Schmidt C; Schnitker J; Schwarz J; Zeitz M; Caspary W · Inflammatory bowel diseases · 2011
    Randomized trial108 participantsAnti-Inflammatory Support forBoswellia
  3. Double-blind trial of solid lipid Boswellia serrata particles (SLBSP) vs. standardized Boswellia serrata gum extract (BSE) for osteoarthritis of knee.
    Kulkarni PD; Damle ND; Singh S; Yadav KS; Ghante MR; Bhaskar VH; Hingorani L; Gota VS · Drug metabolism and personalized therapy · 2021
    Randomized trialAnti-Inflammatory Support forBoswellia
  4. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsJoint Health Anti-Inflammatory Support forBoswellia
  5. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsJoint Health Anti-Inflammatory Support forBoswellia
  6. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsAnti-Inflammatory Support forBoswellia
  7. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  8. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsAnti-Inflammatory Support Joint Health forBoswellia
  9. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health Anti-Inflammatory Support forBoswellia
  10. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsAnti-Inflammatory Support forBoswellia
  11. Efficacy and Safety of Aflapin®, a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study.
    Karlapudi V; Sunkara KB; Konda PR; Sarma KV; Rokkam MP · Journal of the American Nutrition Association · 2023
    Randomized trial70 participantsJoint Health forBoswellia
  12. Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis.
    Zhang Y; Gui Y; Adams R; Farragher J; Itsiopoulos C; Bow K; Cai M; Han J · Nutrients · 2025
    Meta-analysis4,599 participants39 studies pooledJoint Health forBoswellia
  13. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis.
    Bannuru RR; Osani MC; Al-Eid F; Wang C · Seminars in arthritis and rheumatism · 2019
    Meta-analysis1,009 participants11 studies pooledJoint Health forBoswellia
  14. A full-spectrum Boswellia serrata extract with enhanced bioavailability, and its co-delivered system with curcumin alleviate pain and stiffness associated with moderate spondylitis: a randomized double-blind, placebo-controlled, 3-arm study.
    Mamatha K; Prabhakaran P; Syam Das S; Kanjoormana Aryan M; Thomas J · Frontiers in pharmacology · 2025
    Randomized trial105 participantsAnti-Inflammatory Support forBoswellia
  15. Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study.
    Sengupta K; Krishnaraju AV; Vishal AA; Mishra A; Trimurtulu G; Sarma KV; Raychaudhuri SK; Raychaudhuri SP · International journal of medical sciences · 2011
    Randomized trial60 participantsJoint Health forBoswellia
  16. Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities.
    Efferth T; Oesch F · Seminars in cancer biology · 2022
    Systematic reviewAnti-Inflammatory Support forBoswellia
  17. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia